Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,358,818 papers from all fields of science
Search
Sign In
Create Free Account
ifosfamide/vinorelbine
Known as:
IFF/VNB
, Ifosfamide-Vinorelbine
, Ifosfamide-Vinorelbine Regimen
A regimen consisting of ifosfamide and vinorelbine used for the treatment of relapsed or refractory Hodgkin's lymphoma.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Ifosfamide
Vinorelbine tartrate
vinorelbine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Expression of ERCC1 and TUBB3 in Locally Advanced Cervical Squamous Cell Cancer and its Correlation with Different Therapeutic Regimens
A. Zwenger
,
G. Grosman
,
+6 authors
B. Leone
International Journal of Biological Markers
2015
Corpus ID: 10550834
Background Several studies in solid tumors have shown that expression of excision repair cross-complementation group 1 (ERCC1…
Expand
2004
2004
Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer
P. Pronzato
,
P. Queirolo
,
+4 authors
F. Cafiero
Breast Cancer Research and Treatment
2004
Corpus ID: 35441759
The new combination of ifosfamide and vinorelbine wasevaluated in a phase II study of patientswith metastatic breast cancer. All…
Expand
2002
2002
Docetaxel (taxotere) in the treatment of non-small cell lung cancer.
V. Georgoulias
Current Medicinal Chemistry
2002
Corpus ID: 32279795
Docetaxel is a new semi-synthetic anticancer agent derived from bacatin III of the needles of the European yew Taxus baccata…
Expand
2001
2001
Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma
M. Magagnoli
,
B. Sarina
,
+7 authors
A. Santoro
Bone Marrow Transplantation
2001
Corpus ID: 22250718
The mobilizing potential and therapeutic activity of ifosfamide/vinorelbine-containing regimens with G-CSF support were explored…
Expand
2001
2001
Cisplatin/gemcitabine (CG) vs cisplatin/gemcitabine/vinorelbine (CGV) vs sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine (gv/iv) in advanced non-small cell lung…
C. Camps
,
V. Alberola
,
+7 authors
U. Jiménez
2001
Corpus ID: 72100436
2000
2000
Cisplatin/gemcitabine (CG) vs cisplatin/gemcitabine/vinorelbine (CGV) vs sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine (GV/IV) in advanced non-small cell lung…
V. Alberola
,
C. Camps
,
+9 authors
R. Rosell
2000
Corpus ID: 71899197
Review
1998
Review
1998
A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung.
G. Masters
,
P. Hoffman
,
L. Drinkard
,
B. Samuels
,
H. Golomb
,
E. Vokes
Seminars in Oncology
1998
Corpus ID: 39175165
Ifosfamide and vinorelbine have demonstrated single-agent activity against advanced non-small cell lung cancer. The dose-limiting…
Expand
1997
1997
Phase II study of vinorelbine and ifosfamide in anthracycline resistant metastatic breast cancer.
P. Pronzato
,
P. Queirolo
,
+4 authors
F. Cafiero
Breast Cancer Research and Treatment
1997
Corpus ID: 44670530
The new combination of ifosfamide and vinorelbine was evaluated in a phase II study of patients with metastatic breast cancer…
Expand
1996
1996
Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
P. Hoffman
,
G. Masters
,
+4 authors
E. Vokes
Seminars in Oncology
1996
Corpus ID: 11769417
Two studies were performed to determine the maximum tolerated dose (MTD) of paclitaxel and vinorelbine, respectively, in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE